(1)
ROY, S. COMPARATIVE EVALUATION BETWEEN QUALITY OF LIFE (QOL), ADVERSE EVENTS AND SURVIVAL ANALYSIS OF ISCADOR FOR THE TREATMENT OF SOLID TUMORS. Asian J Pharm Clin Res 2014, 7, 9-13.